Frontier Wealth Management LLC Abb Vie Inc. Transaction History

Frontier Wealth Management LLC

$8.02 Billion
Q2 2022

A detailed history of Frontier Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Frontier Wealth Management LLC holds 43,465 shares of ABBV stock, worth $7.46 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

43,465

Previous 43,465 -0.0%

Holding current value

$7.46 Million

Previous $7.27 Million -0.0%

% of portfolio

0.09%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.2 Million - $1.53 Million	8,734 Added 20.09%	52,199 $8 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.97 Million - $2.44 Million	-14,920 Reduced 25.55%	43,465 $7.27 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $140,088 - $177,252	1,304 Added 2.28%	58,385 $7.91 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $170,452 - $193,489	1,602 Added 2.89%	57,081 $6.16 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $410,108 - $456,884	3,898 Added 7.56%	55,479 $6.25 Million

Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $30,587 - $33,673	-299 Reduced 0.58%	51,581 $5.58 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $723,685 - $977,051	8,991 Added 20.96%	51,880 $5.56 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $145,703 - $171,007	1,696 Added 4.12%	42,889 $3.76 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $392,382 - $525,066	5,348 Added 14.92%	41,193 $4.04 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $1.77 Million - $2.69 Million	27,514 Added 330.26%	35,845 $2.73 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $846,517 - $1.06 Million	-11,736 Reduced 58.48%	8,331 $738,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $27,207 - $32,711	-432 Reduced 2.11%	20,067 $1.52 Million
Q2 2019 Aug 16, 2019	BUY	$65.7 - $83.98 $10,314 - $13,184	157 Added 0.77%	20,499 $1.49 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $41,655 - $49,026	-540 Reduced 2.59%	20,342 $1.64 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $176,174 - $217,270	-2,263 Reduced 9.78%	20,882 $1.93 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $70,861 - $78,775	797 Added 3.57%	23,145 $2.19 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $59,524 - $70,430	663 Added 3.06%	22,348 $2.07 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $264,160 - $353,735	2,871 Added 15.26%	21,685 $2.05 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $252,469 - $276,853	-2,819 Reduced 13.03%	18,814 $1.82 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $34,994 - $44,699	501 Added 2.37%	21,633 $1.92 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,132	21,132 $1.53 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.

Account

Frontier Wealth Management LLC Abb Vie Inc. Transaction History